Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.8 DKK | +0.33% | +1.32% | +12.20% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 869M 6.06B | Sales 2025 * | 945M 6.59B | Capitalization | 1.88B 13.13B |
---|---|---|---|---|---|
Net income 2024 * | 72M 502M | Net income 2025 * | 86M 599M | EV / Sales 2024 * | 2.64 x |
Net Debt 2024 * | 412M 2.87B | Net Debt 2025 * | 383M 2.67B | EV / Sales 2025 * | 2.4 x |
P/E ratio 2024 * |
25
x | P/E ratio 2025 * |
21
x | Employees | 3,999 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.44% |
Latest transcript on Embla Medical hf.
1 day | +0.33% | ||
1 week | +3.36% | ||
Current month | -8.06% | ||
1 month | -10.47% | ||
3 months | +2.92% | ||
6 months | +8.26% | ||
Current year | +12.20% |
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 30.8 | +0.33% | 76,638 |
24-04-23 | 30.7 | +1.99% | 68,158 |
24-04-22 | 30.1 | -2.27% | 3,436 |
24-04-19 | 30.8 | +4.41% | 5,428 |
24-04-18 | 29.5 | -2.96% | 12,883 |
Delayed Quote Nasdaq Copenhagen, April 24, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.20% | 1.88B | |
+1.11% | 23.96B | |
-7.00% | 16.71B | |
+7.14% | 13.7B | |
+8.38% | 10.08B | |
-19.75% | 2.03B | |
+36.69% | 1.6B | |
0.00% | 495M | |
+31.01% | 142M | |
+34.50% | 106M |
- Stock Market
- Equities
- EMBLA Stock